These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 11701766)

  • 1. A comparison of morphine-induced locomotor activity and mesolimbic dopamine release in C57BL6, 129Sv and DBA2 mice.
    Murphy NP; Lam HA; Maidment NT
    J Neurochem; 2001 Nov; 79(3):626-35. PubMed ID: 11701766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The NOP (ORL1) receptor antagonist Compound B stimulates mesolimbic dopamine release and is rewarding in mice by a non-NOP-receptor-mediated mechanism.
    Koizumi M; Sakoori K; Midorikawa N; Murphy NP
    Br J Pharmacol; 2004 Sep; 143(1):53-62. PubMed ID: 15289286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A ghrelin receptor (GHS-R1A) antagonist attenuates the rewarding properties of morphine and increases opioid peptide levels in reward areas in mice.
    Engel JA; Nylander I; Jerlhag E
    Eur Neuropsychopharmacol; 2015 Dec; 25(12):2364-71. PubMed ID: 26508707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basal and morphine-evoked dopaminergic neurotransmission in the nucleus accumbens of MOR- and DOR-knockout mice.
    Chefer VI; Kieffer BL; Shippenberg TS
    Eur J Neurosci; 2003 Oct; 18(7):1915-22. PubMed ID: 14622224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strain differences in the rewarding and dopamine-releasing effects of morphine in rats.
    Shoaib M; Spanagel R; Stohr T; Shippenberg TS
    Psychopharmacology (Berl); 1995 Jan; 117(2):240-7. PubMed ID: 7753973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-administration of dextromethorphan with morphine attenuates morphine rewarding effect and related dopamine releases at the nucleus accumbens.
    Huang EY; Liu TC; Tao PL
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Nov; 368(5):386-92. PubMed ID: 14564449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased rewarding properties of morphine in dopamine-transporter knockout mice.
    Spielewoy C; Gonon F; Roubert C; Fauchey V; Jaber M; Caron MG; Roques BP; Hamon M; Betancur C; Maldonado R; Giros B
    Eur J Neurosci; 2000 May; 12(5):1827-37. PubMed ID: 10792459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of naloxone on morphine-induced changes in striatal dopamine metabolism and glutamate, ascorbic acid and uric acid release in freely moving rats.
    Enrico P; Mura MA; Esposito G; Serra P; Migheli R; De Natale G; Desole MS; Miele M; Miele E
    Brain Res; 1998 Jun; 797(1):94-102. PubMed ID: 9630540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphine reward in dopamine-deficient mice.
    Hnasko TS; Sotak BN; Palmiter RD
    Nature; 2005 Dec; 438(7069):854-7. PubMed ID: 16341013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility to conditioned place preference induced by addictive drugs in mice of the C57BL/6 and DBA/2 inbred strains.
    Orsini C; Bonito-Oliva A; Conversi D; Cabib S
    Psychopharmacology (Berl); 2005 Sep; 181(2):327-36. PubMed ID: 15864555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine and serotonin release in dorsal striatum and nucleus accumbens is differentially modulated by morphine in DBA/2J and C57BL/6J mice.
    Fadda P; Scherma M; Fresu A; Collu M; Fratta W
    Synapse; 2005 Apr; 56(1):29-38. PubMed ID: 15700287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine in the medial prefrontal cortex controls genotype-dependent effects of amphetamine on mesoaccumbens dopamine release and locomotion.
    Ventura R; Alcaro A; Cabib S; Conversi D; Mandolesi L; Puglisi-Allegra S
    Neuropsychopharmacology; 2004 Jan; 29(1):72-80. PubMed ID: 12968132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prefrontal cortical norepinephrine release is critical for morphine-induced reward, reinstatement and dopamine release in the nucleus accumbens.
    Ventura R; Alcaro A; Puglisi-Allegra S
    Cereb Cortex; 2005 Dec; 15(12):1877-86. PubMed ID: 15728739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omega-3 fatty acid deficiency augments amphetamine-induced behavioral sensitization in adult DBA/2J mice: relationship with ventral striatum dopamine concentrations.
    McNamara RK; Sullivan J; Richtand NM; Jandacek R; Rider T; Tso P; Campbell N; Lipton J
    Synapse; 2008 Oct; 62(10):725-35. PubMed ID: 18651642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of nitrous oxide on dopamine release in the rat nucleus accumbens and expectation of reward.
    Benturquia N; Le Marec T; Scherrmann JM; Noble F
    Neuroscience; 2008 Aug; 155(2):341-4. PubMed ID: 18571333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of the morphine-induced rewarding effect in the rat with neuropathic pain: implication of the reduction in mu-opioid receptor functions in the ventral tegmental area.
    Ozaki S; Narita M; Narita M; Iino M; Sugita J; Matsumura Y; Suzuki T
    J Neurochem; 2002 Sep; 82(5):1192-8. PubMed ID: 12358766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the endogenous kappa opioid agonist dynorphin A(1-17) on cocaine-evoked increases in striatal dopamine levels and cocaine-induced place preference in C57BL/6J mice.
    Zhang Y; Butelman ER; Schlussman SD; Ho A; Kreek MJ
    Psychopharmacology (Berl); 2004 Apr; 172(4):422-9. PubMed ID: 14712335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential activation of dopaminergic systems in rat brain basal ganglia by morphine and methamphetamine.
    Mori T; Iwase Y; Saeki T; Iwata N; Murata A; Masukawa D; Suzuki T
    Neuroscience; 2016 May; 322():164-70. PubMed ID: 26820597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological Modulation of 5-HT
    Browne CJ; Ji X; Higgins GA; Fletcher PJ; Harvey-Lewis C
    Neuropsychopharmacology; 2017 Oct; 42(11):2178-2187. PubMed ID: 28720903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced morphine-induced behavioural effects and dopamine release in the nucleus accumbens in a transgenic mouse model of impaired glucocorticoid (type II) receptor function: influence of long-term treatment with the antidepressant moclobemide.
    Sillaber I; Montkowski A; Landgraf R; Barden N; Holsboer F; Spanagel R
    Neuroscience; 1998 Jul; 85(2):415-25. PubMed ID: 9622241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.